Kronos Bio Future Growth
Future criteria checks 2/6
Kronos Bio is forecast to grow earnings and revenue by 7.5% and 50.8% per annum respectively while EPS is expected to grow by 14% per annum.
Key information
7.5%
Earnings growth rate
14.0%
EPS growth rate
| Biotechs earnings growth | 23.7% |
| Revenue growth rate | 50.8% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 03 May 2024 |
Recent future growth updates
Recent updates
Is Kronos Bio (NASDAQ:KRON) In A Good Position To Invest In Growth?
Jan 19
We're Keeping An Eye On Kronos Bio's (NASDAQ:KRON) Cash Burn Rate
Aug 21We Think Kronos Bio (NASDAQ:KRON) Needs To Drive Business Growth Carefully
Feb 22Is Kronos Bio (NASDAQ:KRON) In A Good Position To Deliver On Growth Plans?
Nov 01Kronos Bio, Invivoscribe to develop companion diagnostic for leukemia drug entospletinib
Aug 16Is Kronos Bio (NASDAQ:KRON) In A Good Position To Invest In Growth?
Jul 07We're Hopeful That Kronos Bio (NASDAQ:KRON) Will Use Its Cash Wisely
Feb 01How Much Of Kronos Bio, Inc. (NASDAQ:KRON) Do Insiders Own?
Mar 03Read This Before Selling Kronos Bio, Inc. (NASDAQ:KRON) Shares
Jan 09
Kronos Bio EPS misses by $4.10
Nov 18Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | N/A | -152 | -127 | N/A | 2 |
| 12/31/2025 | 3 | -94 | -98 | N/A | 3 |
| 12/31/2024 | 5 | -90 | -103 | N/A | 4 |
| 12/31/2023 | 6 | -113 | -79 | -79 | N/A |
| 9/30/2023 | 4 | -119 | -77 | -76 | N/A |
| 6/30/2023 | 3 | -120 | -76 | -76 | N/A |
| 3/31/2023 | 1 | -123 | -74 | -73 | N/A |
| 12/31/2022 | N/A | -133 | -92 | -91 | N/A |
| 9/30/2022 | N/A | -164 | -128 | -127 | N/A |
| 6/30/2022 | N/A | -165 | -127 | -125 | N/A |
| 3/31/2022 | N/A | -161 | -126 | -122 | N/A |
| 12/31/2021 | N/A | -151 | -122 | -118 | N/A |
| 9/30/2021 | N/A | -122 | -82 | -75 | N/A |
| 6/30/2021 | N/A | -128 | -76 | -65 | N/A |
| 3/31/2021 | N/A | -108 | -60 | -50 | N/A |
| 12/31/2020 | N/A | -88 | -47 | -38 | N/A |
| 9/30/2020 | N/A | -61 | -34 | -27 | N/A |
| 6/30/2020 | N/A | -25 | -24 | -20 | N/A |
| 3/31/2020 | N/A | -20 | -22 | -19 | N/A |
| 12/31/2019 | N/A | -16 | -18 | -15 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: KRON is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: KRON is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: KRON is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: KRON's revenue (50.8% per year) is forecast to grow faster than the US market (8.2% per year).
High Growth Revenue: KRON's revenue (50.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if KRON's Return on Equity is forecast to be high in 3 years time